Loading clinical trials...
Loading clinical trials...
A Phase 1 Study to Evaluate the Safety and Efficacy of DISP-10 in Participants With Advanced Gastrointestinal Cancers
Conditions
Interventions
DISP-10
Locations
2
United States
City of Hope
Duarte, California, United States
Tennessee Oncology
Nashville, Tennessee, United States
Start Date
April 1, 2026
Primary Completion Date
April 1, 2046
Completion Date
April 1, 2046
Last Updated
April 22, 2026
NCT07446322
NCT06340711
NCT07541924
NCT04693377
NCT07416552
NCT07529301
Lead Sponsor
Dispatch Biotherapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions